New Braasch Biotech Vaccine Technology Provides Growth Hormone And IGF-1 Treatments Without The Use Of Drugs

Braasch Biotech LLC announces its lead vaccine for Obesity, Growth Hormone Deficiencies may have beneficial use for numerous IGF-1 responsive disorders such as diabetes, heart disease and Rett Syndrome based on initial preclinical testing in a mouse model.